题名 | Letter to the Editor: Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease |
作者 | |
发表期刊 | Metabolism: clinical and experimental 影响因子和分区 |
语种 | 英语 |
原始文献类型 | Article |
关键词 | COVID-19 MAFLD Obesity SARS-CoV-2. |
ISSN | 0026-0495 |
EISSN | 1532-8600 |
卷号 | 108页码:154244 |
DOI | 10.1016/j.metabol.2020.154244 |
收录类别 | PUBMED ; SCOPUS |
发表日期 | 2020-07-01 |
URL | 查看原文 |
Pubmed记录号 | 32320741 |
PMC记录号 | PMC7166301 |
Scopus记录号 | 2-s2.0-85083900952 |
引用统计 | |
文献类型 | 期刊论文 |
条目标识符 | https://kms.wmu.edu.cn/handle/3ETUA0LF/33439 |
专题 | 附属第一医院 第一临床医学院(信息与工程学院)、附属第一医院_影像医学与核医学_放射科 |
作者单位 | 1.MAFLD Research Center, Department of Hepatology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.; 2.Department of Gastroenterology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.; 3.Department of Critical Care Medicine, Wenzhou Central Hospital, Wenzhou, China.; 4.Department of Infectious Diseases, Ruian People&s Hospital, Wenzhou, China.; 5.Department of Radiology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.; 6.Department of Nephrology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.; 7.Department of Endocrinology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.; 8.Storr Liver Centre, Westmead Institute for Medical Research, Westmead Hospital and University of Sydney, Sydney, Australia. Electronic address: jacob.george@sydney.edu.au.; 9.MAFLD Research Center, Department of Hepatology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China; Institute of Hepatology, Wenzhou Medical University, Wenzhou, China; Key Laboratory of Diagnosis and Treatment for The Development of Chronic Liver Disease in Zhejiang Province, Wenzhou, China. |
第一作者单位 | 附属第一医院; 第一临床医学院(信息与工程学院)、附属第一医院 |
第一作者的第一单位 | 附属第一医院 |
推荐引用方式 GB/T 7714 | Kenneth I Zheng,Feng Gao,Xiao-Bo Wang,et al. Letter to the Editor: Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease[J]. Metabolism: clinical and experimental,2020,108:154244. |
APA | Kenneth I Zheng., Feng Gao., Xiao-Bo Wang., Qing-Feng Sun., Ke-Hua Pan., ... & Ming-Hua Zheng. (2020). Letter to the Editor: Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease. Metabolism: clinical and experimental, 108, 154244. |
MLA | Kenneth I Zheng,et al."Letter to the Editor: Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease".Metabolism: clinical and experimental 108(2020):154244. |
条目包含的文件 | 条目无相关文件。 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论